MONTREAL, Aug. 29 /CNW Telbec/ - (TSX-V: BUG) - Biophage Pharma Inc.
(TSX.V: BUG) announced today that it is developing an innovative integrated
approach for the management of bacterial contamination in hospitals. The
tandem development of its PDS(R) Biosensor will identify Antibiotic Resistant
bacteria and the novel approaches to phage therapy will then be applied to
contain these infections.
